Publications by authors named "Chrissy Lowry"

Claim this Profile
C
Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung Cancer in Sweden.
Jaesh Naik, Norma Beavers, Fredrik O L Nilsson, Laura Iadeluca, Chrissy Lowry

Appl Health Econ Health Policy· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Lorlatinib in Patients Previously Treated with Anaplastic Lymphoma Kinase Inhibitors for Non-small Cell Lung Cancer in Greece.
George Gourzoulidis, Oresteia Zisimopoulou, Nadia Boubouchairopoulou, Christina Michailidi, Chrissy Lowry

J Health Econ Outcomes Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis